This Is MS Multiple Sclerosis Knowledge & Support Community

Hi, I recall a trial about Intrathecal Methotrexate some time ago. This job was presented at one of the annual conferences on MS. As far as I recall, altought Methotrexate given thru standard means is not very effective for most people, it showed good results given in this way. I believe it showed s...

I would like Bromley to stay.

Anecdote, (...) I think you are the only case of someone with SPMS who has shown that the damage can be reversed and this is due to the treatment you are receiving. All the best. Bromley. Some treatments cause improvements also in individuals with SPMS. The most important case (my opinion) is Novan...

The following info about the two PML cases associated with T was recently posted in BrainTalk: Case 1- The person who died had 37 doses of tysabri along with avonex. The last dose was on jan 15, 2005. On Dec. 4 she experienced right-sided weakness and aphasis, which was initially considered an MS re...

Any news about the trial results that ended last November ?

Thanks in advance

Riccardo

About this discussion, I simply do not understand why Tysabri should be labeled as for " mild " RRMS only. Based on what we know, it should be for RRMS and do better than CRABs. So, not just for mild cases. Also, it should provide some help for relapsing SPMS. Of course, I agree that it wo...

If I am not wrong, a trial involving Aimspro in ON has just been completed.

Results should come out in the close future.

I hope for a positive outcome, Aimspro looks very promising and is one of the very few drugs targeting (also) progressive MS.

Riccardo

Thanks.

Ric

Dear all,

I have not heard much about Campath in the last months. News about Campath looked very promising only one year ago. Anybody knows anything about current research and trials ?

Thanks

Ric